Nusano News

Anson Signs Non-Binding MOU Lithium Chloride Offtake Agreement with Nusano

Dec. 8, 2025 – The following is a copy of an ASX announcement issued by Anson Resources. The original annoucement can be viewed on Anson's website. Anson Signs...

Nusano Named Researcher of the Year at Inaugural Best of BioHive Awards

Feb 21, 2025

[dsm_image_carousel gallery_ids="292288,292284,292285,292287,292286,292280" sizes="thumbnail" lazyload="on" centered_slides="on" autoplay_speed="4000" show_lightbox="on" _builder_version="4.27.4" _module_preset="default" global_colors_info="{}"...

Nusano to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 7, 2025

WEST VALLEY CITY, Utah – Feb. 7, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CFO Pushkar Bedekar will present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11,...

Nusano to Present at Piper Sandler Next-Gen RadioPharma Symposium

Jan 22, 2025

VALENCIA, Calif. – Jan. 22, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CEO Chris Lowe will present at Piper Sandler’s Nex-Gen RadioPharma Symposium virtual event on Thursday, Jan. 23, 2025. The fireside...

Nusano and Caspian Studios Announce Launch of Talk Radioisotopes Podcast

Jan 22, 2025

Premier episode available today across all podcast platformsVALENCIA, Calif. – Jan. 22, 2025 – Nusano, a physics company transforming the production of radioisotopes, and Caspian Studios, an award-winning content-as-a-service studio, today announced the launch of the...

Nusano and Atley Solutions in Collaboration to Accelerate Astatine-211 Development

Jan 16, 2025

Nusano isotope production to deliver breakthrough, 100X increase in global At-211 supply, and Atley’s radiopharmaceutical manufacturing technology to enable scalable At-211 radiopharmaceutical supplyVALENCIA, Calif. and GOTHENBURG, Sweden – Jan. 16, 2025 – Nusano, a...

Nusano to Host Virtual KOL Panel Discussion on December 17, 2024 Previewing the Year Ahead in Radioligand Therapy (RLT)

Dec 11, 2024

VALENCIA, Calif. – Dec. 11, 2024 – Nusano, a physics company transforming the production of radioisotopes, today announced it will host a virtual key opinion leader (KOL) panel discussion on Tuesday, December 17, 2024 at 1:00 PM ET to preview the year ahead in...

Nusano and GlyTherix Announce Lutetium-177 Supply Agreement

Dec 9, 2024

VALENCIA, Calif. and SYDNEY, Australia – Dec. 9, 2024 – Nusano, a physics company transforming the production of radioisotopes, and GlyTherix Ltd (GlyTherix) an Australian targeted radiotherapy company specializing in developing antibody radiopharmaceuticals for solid...

Nusano Names Medical Radioisotopes Advisory Board

Dec 3, 2024

Nusano names five member Medical Radioisotope Advisory Board

Nusano to Present at William Blair Virtual Radiopharmaceuticals Event

Nov 12, 2024

VALENCIA, Calif. – November 12, 2024 – Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CEO Chris Lowe will present at William Blair’s Innovators Series: Radiopharmaceuticals virtual event on Thursday, November 14,...

Nusano and Starget Pharma Announce Supply Agreement to Accelerate Smart Targeted Radioligand Development

Oct 17, 2024

Image above: Starget Pharma, stargetpharma.comVALENCIA, Calif. and TEL AVIV, Israel – Oct. 17, 2024 – Nusano, a physics company transforming the production of radioisotopes, and Starget Pharma, a clinical-stage biotechnology company developing precision peptide...